Literature DB >> 3555318

The pharmacology of carnitine.

J J Bahl, R Bressler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3555318     DOI： 10.1146/annurev.pa.27.040187.001353

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  17 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients.

Authors:  Y Kudoh; S Aoyama; T Torii; Q Chen; D Nagahara; H Sakata; A Nozawa
Journal:  Cardiorenal Med       Date:  2013-09-27       Impact factor: 2.041

Review 3.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

4.  Effect of D,L-carnitine on the response of the isolated heart of the rat to ischaemia and reperfusion: relation to mitochondrial function.

Authors:  J M Duan; M Karmazyn
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

5.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

6.  [Decreased plasma carnitine in Type I diabetes mellitus].

Authors:  P Pregant; G Schernthaner; E Legenstein; L Lienhart; S Bruck; C Schnack; E Kaiser
Journal:  Klin Wochenschr       Date:  1991-08-16

7.  No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients.

Authors:  P Pregant; E Kaiser; G Schernthaner
Journal:  Clin Investig       Date:  1993-08

Review 8.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo.

Authors:  Pernille R Jensen; Torben Peitersen; Magnus Karlsson; René In 't Zandt; Anna Gisselsson; Georg Hansson; Sebastian Meier; Mathilde H Lerche
Journal:  J Biol Chem       Date:  2009-10-27       Impact factor: 5.157

10.  Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin.

Authors:  David B Engle; Jennifer A Belisle; Jennifer A A Gubbels; Sarah E Petrie; Paul R Hutson; David M Kushner; Manish S Patankar
Journal:  Gynecol Oncol       Date:  2009-03       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.